Back in February, I wrote Markets in (semi)Panic. At the time, markets were down ~5% on the year and ~10% from their all time highs they had reached just a few weeks before.
In yesterday's post, I introduced my Christmas Ideas for 2019 series (I wrote it early morning and somehow managed to misspell Christmas in the title; a misspelling that will live in infamy on twitter for the rest of time). Today I wanted to run through some "honorable mention" ideas that I thought about profiling for […]
A failed Phase II trial for their main drug caused investors to abandon MEI Pharma (MEIP) Today, the company trades for below net cash Despite the failed trial, some recent good news suggest there could be significant upside potential hiding here This week the blog is focused on companies trading for less than cash value. […]
A failed Phase II trial for their main drug caused investors to abandon MEI Pharma (MEIP) Today, the company trades for below net cash Despite the failed trial, some recent good news suggest there could be significant upside potential hiding here This week the blog is focused on companies trading for less than cash value. […]
Join the Mailing List
Enter your email address to subscribe to this blog and receive notifications of new posts by email.
